• 

  February 10, 2021

  STAMP Inhibitor Scemblix for CML

  Charles H. Weaver, MD

• 

  March 6, 2020

  Iclusig (ponatinib) Treatment of Chronic Myelod Leukemia

  Charles H. Weaver, MD

• 

  May 7, 2019

  Two Year TKI Consolidation Allowed for TKI Cessation in Select Patients With CML

  Charles H. Weaver, MD

• 

  May 3, 2019

  Understanding TKI Therapy and Drug Resistance in Chronic Myelogenous Leukemia

  Charles H. Weaver, MD

• 

  September 26, 2018

  Treatment of Accelerated & Blastic Phase Chronic Myeloid Leukemia

  Charles H. Weaver, MD